Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Body composition refers to the quantification of different components within the human body—primarily fat mass, lean tissue/muscle mass, bone mineral content, and water. Various models exist for its assessment: * Two-compartment model:* divides into fat mass and fat-free mass. * Multi-compartment models:* further separate water, protein/muscle tissue, minerals/bone content. Measurement techniques include skinfold calipers for subcutaneous fat estimation; bioelectrical impedance analysis; dual-energy X-ray absorptiometry (DXA); MRI/CT imaging; ultrasound-based methods. Accurate assessment provides insight into nutritional status and disease risk but does not represent a discrete molecular or pharmacological target. Rather than being targeted by drugs directly, changes in body composition result from lifestyle interventions or medications affecting metabolism/hormones.[7][5][1] In summary: Body composition should not be classified as a canonical drug target—it is an aggregate physiological measure rather than a specific molecular entity suitable for direct pharmacologic targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Body composition.